...
首页> 外文期刊>Frontiers in Physiology >Sanhua Decoction, a Classic Herbal Prescription, Exerts Neuroprotection Through Regulating Phosphorylated Tau Level and Promoting Adult Endogenous Neurogenesis After Cerebral Ischemia/Reperfusion Injury
【24h】

Sanhua Decoction, a Classic Herbal Prescription, Exerts Neuroprotection Through Regulating Phosphorylated Tau Level and Promoting Adult Endogenous Neurogenesis After Cerebral Ischemia/Reperfusion Injury

机译:Sanhua汤剂,一种经典的草药处方,通过调节磷酸化TAU水平并在脑缺血/再灌注损伤后促进成人内源神经发生的神经保护作用

获取原文

摘要

Background: Ischemia stroke is the leading cause of death and long-term disability. Sanhua Decoction (SHD), a classic Chinese herbal prescription, has been used for ischemic stroke for about thousands of years. Here, we aim to investigate the neuroprotective effects of SHD on cerebral ischemia/reperfusion (CIR) injury rat models. Methods: The male Sprague-Dawley rats (body weight, 250–280 g; age, 7–8 weeks) were randomly divided into sham group, CIR group, and SHD group and were further divided into subgroups according to different time points at 6 h, 1, 3, 7, 14, 21, and 28 d, respectively. The SHD group received intragastric administration of SHD at 10 g kg ~(?1) d ~(?1). The focal CIR models were induced by middle cerebral artery occlusion according to Longa’s method, while sham group had the same operation without suture insertion. Neurological deficit score (NDS) was evaluated using the Longa’s scale. BrdU, doublecortin (DCX), and glial fibrillary acidic protein (GFAP) were used to label proliferation, migration, and differentiation of nerve cells before being observed by immunofluorescence. The expression of reelin, total tau (t-tau), and phosphorylated tau (p-tau) were evaluated by western blot and RT-qPCR. Results: SHD can significantly improve NDS at 1, 3, 7, and 14 d ( p & 0.05), increase the number of BrdU positive and BrdU/DCX positive cells in subventricular zone at 3, 7, and 14 d ( p & 0.05), upregulate BrdU/GFAP positive cells in the ischemic penumbra at 28 d after CIR ( p & 0.05), and reduce p-tau level at 1, 3, 7, and 14 d ( p & 0.05). There was no significant difference on reelin and t-tau level between three groups at each time points after CIR. Conclusions: SHD exerts neuroprotection probably by regulating p-tau level and promoting the proliferation, migration, and differentiation of endogenous neural stem cells, accompanying with neurobehavioral recovery.
机译:背景:缺血中风是死亡和长期残疾的主要原因。 Sanhua汤(Shd)是一种经典的中草药处方,已被用于缺血性卒中大约数千年。在这里,我们的目的是研究SHD对脑缺血/再灌注(CIR)损伤大鼠模型的神经保护作用。方法:雄性Sprague-Dawley大鼠(体重,250-280g;年龄,7-8周)随机分为假组,CIR组和SHD组,并根据6的不同时间点进一步分为亚组H,1,3,7,14,21和28d分别。 SHD组接受了10g kg〜(α1)d〜(α1)的SHD的胃内给药。根据Longa的方法,焦致性的焦点模型由中脑动脉闭塞诱导,而假手术的手术在没有缝合插入的情况下具有相同的操作。使用Longa的规模评估神经系统缺陷分数(NDS)。在通过免疫荧光观察之前,使用Brdu,DoubleRecortin(DCx)和胶质纤维酸性蛋白(GFAP)标记神经细胞的增殖,迁移和分化。通过蛋白质印迹和RT-QPCR评估Reelin,Tau Tau(T-Tau)和磷酸化Tau(p-tau)的表达。结果:SHD可以显着改善1,3,7和14d(P <0.05),增加3,7和14d(P&LT)的子腔区中Brdu阳性和Brdu / DCx阳性细胞的数量; 0.05),在CIR(P <0.05)后,在28d下在缺血半影中上调BRDU / GFAP阳性细胞,并在1,3,7和14d下降低P-TAU水平(P <0.05)。 CIR后每次点的三组之间的Reelin和T-TAU水平没有显着差异。结论:SHD可能通过调节P-TAU水平并促进内源性神经干细胞的增殖,迁移和分化,伴随着神经软管恢复的增殖,迁移和分化。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号